Sarepta Therapeutics

YTD

ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

2.11B

Market cap2.11B

Price-Earnings ratio

-8.37

Price-Earnings ratio-8.37

Dividend yield

—

Dividend yield—

Average volume

8.65M

Average volume8.65M

High today

$22.98

High today$22.98

Low today

$20.51

Low today$20.51

Open price

$21.11

Open price$21.11

Volume

14.46M

Volume14.46M

52 Week high

$173.25

52 Week high$173.25

52 Week low

$18.30

52 Week low$18.30

SRPT News

Seeking Alpha 2d

Sarepta downgraded as company suspends guidance after latest Elevidys death

Wall Street analysts were quick to downgrade Sarepta Therapeutics (NASDAQ:SRPT) on Monday as the company suspended its revenue guidance for 2025 following a sec...

Sherwood News 2d

Sarepta tumbles after second patient death from gene therapy treatment

Sarepta tumbles after second patient death from gene therapy treatment Sarepta Therapeutics is down nearly 40% in premarket trading after the company disclosed...

Analyst ratings

57%

of 28 ratings

Buy

57.1%

Hold

39.3%

Sell

3.6%

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.